Ocular Graft-versus-host Disease
📧 Sign up to get email alerts when something new happens for Ocular Graft-versus-host Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: RHPRG4 FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD) [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial of RHPRG4 for ocular graft-versus-host disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: Expanded Access for d-MAPPS™ Ophthalmic Solution, in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)
This notice provides expanded access for d-MAPPS ophthalmic solution to treat chronic ocular graft-versus-host disease (oGVHD). Regenerative…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Evaluation of the Safety and Effectiveness of omniLenz in Patient With Ocular Graft vs Host Disease [NA]
A completed clinical trial evaluating the safety and effectiveness of omniLenz in patients with ocular graft-versus-host disease.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating amniotic fluid eye drops for ocular graft-versus-host disease has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Allogeneic Platelet Lysate Eye Drops for the Treatment of Severe Chronic Ocular Graft-versus-host Disease [Phase 2]
A Phase 2 trial evaluating allogeneic platelet lysate eye drops for severe chronic ocular graft-versus-host disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease [Phase 2, Phase 3]
A clinical trial update for Pro-ocular 1% assessing safety and efficacy in daily scleral lens wearers with ocular graft-versus-host disease,…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease [Phase 1, Phase 2]
Clinical trial update on rhDNase eye drops for ocular graft-versus-host disease and dry eye, terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD) [Phase 1, Phase 2]
Phase 1/2 trial of brimonidine eye drops for ocular graft-vs-host disease and dry eye has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease [Phase 2]
A Phase 2 clinical trial evaluated bandage contact lenses for treating ocular complications in graft-versus-host disease, with results poste…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease [Phase 1]
Phase 1 trial evaluating the safety and efficacy of a 0.05% topical tacrolimus formulation for ocular graft-versus-host disease; results hav…
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: Tear Cytokine Analysis as a Prediction or Diagnostic Marker in Ocular GvHD
The trial evaluated tear cytokines as a potential predictor or diagnostic marker for ocular graft-versus-host disease, and the study has com…